Weishaupt J H, Neusch C, Bähr M
Department of Neurology, University Hospital Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Cell Tissue Res. 2003 Apr;312(1):1-8. doi: 10.1007/s00441-003-0703-7. Epub 2003 Mar 26.
Many neurological disorders like Parkinson's and Alzheimer's disease, amyotrophic lateral sclerosis (ALS) or stroke have in common a definite loss of CNS neurons due to apoptotic or necrotic neuronal cell death. Previous studies suggested that proapoptotic stimuli may trigger an abortive and, therefore, eventually fatal cell cycle reentry in postmitotic neurons. Neuroprotective effects of small molecule inhibitors of cyclin-dependent kinases (CDKs), which are key regulators of cell cycle progression, support the cell cycle theory of neuronal apoptosis. However, growing evidence suggests that deregulated CDK5, which is not involved in cell cycle control, rather than cell cycle relevant members of the CDK family, promotes neuronal cell death. Here we summarize the current knowledge about the involvement of CDK5 in neuronal cell death and discuss possible up- or downstream partners of CDK5. Moreover, we discuss potential therapeutic options that might arise from the identification of CDK5 as an important upstream element of neuronal cell death cascades.
许多神经疾病,如帕金森病、阿尔茨海默病、肌萎缩侧索硬化症(ALS)或中风,都有一个共同特征,即由于凋亡或坏死性神经元细胞死亡,中枢神经系统(CNS)神经元出现明确的损失。先前的研究表明,促凋亡刺激可能会引发有丝分裂后神经元的 abortive 且最终致命的细胞周期重新进入。细胞周期蛋白依赖性激酶(CDK)小分子抑制剂具有神经保护作用,CDK 是细胞周期进程的关键调节因子,这支持了神经元凋亡的细胞周期理论。然而,越来越多的证据表明,失调的 CDK5(其不参与细胞周期控制)而非 CDK 家族中与细胞周期相关的成员,会促进神经元细胞死亡。在这里,我们总结了目前关于 CDK5 参与神经元细胞死亡的知识,并讨论了 CDK5 可能的上游或下游伙伴。此外,我们还讨论了由于将 CDK5 确定为神经元细胞死亡级联反应的重要上游元件而可能产生的潜在治疗选择。